A Study to Compare the Efficacy, Safety, Pharmacokinetics, and Immunogenicity Between SB27 and Keytruda in Subjects With Metastatic Non-squamous Non-small Cell Lung Cancer

PHASE3RecruitingINTERVENTIONAL
Enrollment

616

Participants

Timeline

Start Date

March 12, 2024

Primary Completion Date

September 30, 2025

Study Completion Date

March 31, 2027

Conditions
Non-small Cell Lung Cancer Stage IV
Interventions
DRUG

SB27

Will be administered intravenously at a fixed dose of 200 mg every 3 weeks

DRUG

Keytruda

Will be administered intravenously at a fixed dose of 200 mg every 3 weeks

Trial Locations (91)

Unknown

ACTIVE_NOT_RECRUITING

SB Investigative Site, Banja Luka

ACTIVE_NOT_RECRUITING

SB Investigative Site, Mostar

ACTIVE_NOT_RECRUITING

SB Investigative Site, Sarajevo

ACTIVE_NOT_RECRUITING

SB Investigative Site, Curitiba

ACTIVE_NOT_RECRUITING

SB Investigative Site, Florianópolis

ACTIVE_NOT_RECRUITING

SB Investigative Site, Ijuí

ACTIVE_NOT_RECRUITING

SB Investigative Site, Natal

ACTIVE_NOT_RECRUITING

SB Investigative Site, Pelotas

ACTIVE_NOT_RECRUITING

SB Investigative Site, Porto Alegre

ACTIVE_NOT_RECRUITING

SB Investigative Site, Rio de Janeiro

RECRUITING

SB Investigative Site, Santo André

ACTIVE_NOT_RECRUITING

SB Investigative Site, Batumi

RECRUITING

SB Investigative Site, Tbilisi

ACTIVE_NOT_RECRUITING

SB Investigative Site, Tbilisi

ACTIVE_NOT_RECRUITING

SB Investigative Site, Düsseldorf

WITHDRAWN

SB Investigative Site, Giessen

ACTIVE_NOT_RECRUITING

SB Investigative Site, Halle

WITHDRAWN

SB Investigative Site, Kassel

ACTIVE_NOT_RECRUITING

SB Investigative Site, Moers

ACTIVE_NOT_RECRUITING

SB Investigative Site, Neuss

ACTIVE_NOT_RECRUITING

SB Investigative Site, Bangalore

ACTIVE_NOT_RECRUITING

SB Investigative Site, Bhubaneshwar

ACTIVE_NOT_RECRUITING

SB Investigative Site, Bhubaneswar

ACTIVE_NOT_RECRUITING

SB Investigative Site, Erandwane

ACTIVE_NOT_RECRUITING

SB Investigative Site, Hyderabad

RECRUITING

SB Investigative Site, Jaipur

ACTIVE_NOT_RECRUITING

SB Investigative Site, Jaipur

ACTIVE_NOT_RECRUITING

SB Investigative Site, Mumbai

RECRUITING

SB Investigative Site, Sūrat

ACTIVE_NOT_RECRUITING

SB Investigative Site, Udaipur

ACTIVE_NOT_RECRUITING

SB Investigative Site, Himeji

ACTIVE_NOT_RECRUITING

SB Investigative Site, Iwakuni

ACTIVE_NOT_RECRUITING

SB Investigative Site, Izumi

ACTIVE_NOT_RECRUITING

SB Investigative Site, Kawachi-Nagano

ACTIVE_NOT_RECRUITING

SB Investigative Site, Kobe

ACTIVE_NOT_RECRUITING

SB Investigative Site, Kochi

WITHDRAWN

SB Investigative Site, Okayama

ACTIVE_NOT_RECRUITING

SB Investigative Site, Sagamihara

ACTIVE_NOT_RECRUITING

SB Investigative Site, Tachikawa

ACTIVE_NOT_RECRUITING

SB Investigative Site, Takarazuka

ACTIVE_NOT_RECRUITING

SB Investigative Site, Toyonaka

ACTIVE_NOT_RECRUITING

SB Investigative Site, George Town

ACTIVE_NOT_RECRUITING

SB Investigative Site, Johor Bahru

ACTIVE_NOT_RECRUITING

SB Investigative Site, Kota Bharu

ACTIVE_NOT_RECRUITING

SB Investigative Site, Kuantan

ACTIVE_NOT_RECRUITING

SB Investigative Site, Lembah Pantai

ACTIVE_NOT_RECRUITING

SB Investigative Site, Putrajaya

ACTIVE_NOT_RECRUITING

SB Investigative Site, Aguascalientes

RECRUITING

SB Investigative Site, Guadalajara

ACTIVE_NOT_RECRUITING

SB Investigative Site, Mexico City

ACTIVE_NOT_RECRUITING

SB Investigative Site, Davao City

ACTIVE_NOT_RECRUITING

SB Investigative Site, Makati City

ACTIVE_NOT_RECRUITING

SB Investigative Site, Manila

ACTIVE_NOT_RECRUITING

SB Investigative Site, Quezon City

ACTIVE_NOT_RECRUITING

SB Investigative Site, San Juan City

ACTIVE_NOT_RECRUITING

SB Investigative Site, Cluj-Napoca

ACTIVE_NOT_RECRUITING

SB Investigative Site, Craiova

ACTIVE_NOT_RECRUITING

SB Investigative Site, Iași

ACTIVE_NOT_RECRUITING

SB Investigative Site, Oradea

ACTIVE_NOT_RECRUITING

SB Investigative Site, Sibiu

ACTIVE_NOT_RECRUITING

SB Investigative Site, Suceava

WITHDRAWN

SB Investigative Site, Târgu Mureş

WITHDRAWN

SB Investigative Site, Timișoara

ACTIVE_NOT_RECRUITING

SB Investigative Site, Belgrade

ACTIVE_NOT_RECRUITING

SB Investigative Site, Kamenitz

ACTIVE_NOT_RECRUITING

SB Investigative Site, Kragujevac

ACTIVE_NOT_RECRUITING

SB Investigative Site, Niš

ACTIVE_NOT_RECRUITING

SB Investigative Site, Leganés

WITHDRAWN

SB Investigative Site, Madrid

ACTIVE_NOT_RECRUITING

SB Investigative Site, Málaga

ACTIVE_NOT_RECRUITING

SB Investigative Site, Ourense

ACTIVE_NOT_RECRUITING

SB Investigative Site, Oviedo

WITHDRAWN

SB Investigative Site, Pamplona

ACTIVE_NOT_RECRUITING

SB Investigative Site, Santiago de Compostela

ACTIVE_NOT_RECRUITING

SB Investigative Site, Seville

ACTIVE_NOT_RECRUITING

SB Investigative Site, Valencia

ACTIVE_NOT_RECRUITING

SB Investigative Site, Bangkok

ACTIVE_NOT_RECRUITING

SB Investigative Site, Bangkok Noi

ACTIVE_NOT_RECRUITING

SB Investigative Site, Khon Kaen

ACTIVE_NOT_RECRUITING

SB Investigative Site, Adapazarı

ACTIVE_NOT_RECRUITING

SB Investigative Site, Ankara

ACTIVE_NOT_RECRUITING

SB Investigative Site, Bağcılar

ACTIVE_NOT_RECRUITING

SB Investigative Site, Balgat

ACTIVE_NOT_RECRUITING

SB Investigative Site, Çubuk

ACTIVE_NOT_RECRUITING

SB Investigative Site, Istanbul

ACTIVE_NOT_RECRUITING

SB Investigative Site, İzmit

ACTIVE_NOT_RECRUITING

SB Investigative Site, Kavaklıdere

ACTIVE_NOT_RECRUITING

SB Investigative Site, Konak

ACTIVE_NOT_RECRUITING

SB Investigative Site, Maltepe

ACTIVE_NOT_RECRUITING

SB Investigative Site, Seyhan

ACTIVE_NOT_RECRUITING

SB Investigative Site, Sivas

All Listed Sponsors
lead

Samsung Bioepis Co., Ltd.

INDUSTRY